Bio-Techne Corporation
TECH
$63.26
-$0.56-0.88%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 77.99M | 73.40M | 131.67M | 158.14M | 150.71M |
| Total Depreciation and Amortization | 62.11M | 65.90M | 64.25M | 63.99M | 64.71M |
| Total Amortization of Deferred Charges | 44.00M | 44.00M | 46.60M | 46.60M | 46.60M |
| Total Other Non-Cash Items | 88.73M | 92.71M | 42.60M | 42.44M | 41.33M |
| Change in Net Operating Assets | -21.57M | 11.54M | -20.27M | -6.45M | 134.00K |
| Cash from Operations | 251.25M | 287.56M | 264.85M | 304.72M | 303.49M |
| Capital Expenditure | -27.20M | -31.01M | -44.10M | -50.41M | -58.46M |
| Sale of Property, Plant, and Equipment | 7.06M | 2.45M | 1.79M | 1.79M | -- |
| Cash Acquisitions | -- | -- | 0.00 | 0.00 | -3.28M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 7.24M | -6.62M | -2.09M | -3.34M | -8.87M |
| Cash from Investing | -12.89M | -35.18M | -44.40M | -51.97M | -70.60M |
| Total Debt Issued | 104.00M | 104.00M | 38.00M | 0.00 | 65.00M |
| Total Debt Repaid | -104.00M | -77.00M | -97.00M | -147.00M | -205.00M |
| Issuance of Common Stock | 50.13M | 51.74M | 68.45M | 71.91M | 71.64M |
| Repurchase of Common Stock | -286.52M | -282.25M | -182.36M | -82.20M | -86.67M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -50.15M | -50.39M | -50.63M | -50.63M | -50.45M |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -286.54M | -253.91M | -223.55M | -207.92M | -205.48M |
| Foreign Exchange rate Adjustments | 5.60M | 11.93M | 3.85M | 2.58M | 11.48M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -42.58M | 10.40M | 755.00K | 47.42M | 38.88M |